Wolverine Trading’s Opko Health OPK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-134,700
| Closed | -$198K | – | 5520 |
|
|
2024
Q4 | $198K | Sell |
134,700
-12,200
| -8% | -$18.7K | ﹤0.01% | 4531 |
|
|
2024
Q3 | $223K | Buy |
146,900
+93,900
| +177% | +$139K | ﹤0.01% | 3966 |
|
|
2024
Q2 | $66.3K | Buy |
53,000
+30,600
| +137% | +$39.7K | ﹤0.01% | 4172 |
|
|
2024
Q1 | $26.9K | Buy |
+22,400
| New | +$22.4K | ﹤0.01% | 4311 |
|
|
2023
Q1 | – | Sell |
-19,800
| Closed | -$25K | – | 4744 |
|
|
2022
Q4 | $25K | Buy |
19,800
+100
| +0.5% | +$158 | ﹤0.01% | 3702 |
|
|
2022
Q3 | $37K | Buy |
+19,700
| New | +$46.6K | ﹤0.01% | 4235 |
|
|
2022
Q2 | – | Sell |
-13,600
| Closed | -$48K | – | 5382 |
|
|
2022
Q1 | $48K | Sell |
13,600
-65,700
| -83% | -$232K | ﹤0.01% | 5089 |
|
|
2021
Q4 | $384K | Buy |
+79,300
| New | +$321K | ﹤0.01% | 3809 |
|
|
2021
Q3 | – | Sell |
-45,700
| Closed | -$186K | – | 6750 |
|
|
2021
Q2 | $186K | Sell |
45,700
-18,800
| -29% | -$73.7K | ﹤0.01% | 5064 |
|
|
2021
Q1 | $272K | Sell |
64,500
-56,500
| -47% | -$270K | ﹤0.01% | 4590 |
|
|
2020
Q4 | $489K | Buy |
121,000
+34,800
| +40% | +$145K | ﹤0.01% | 3201 |
|
|
2020
Q3 | $296K | Buy |
86,200
+35,500
| +70% | +$150K | ﹤0.01% | 3417 |
|
|
2020
Q2 | $150K | Sell |
50,700
-21,500
| -30% | -$48.2K | ﹤0.01% | 3981 |
|
|
2020
Q1 | $98K | Sell |
72,200
-18,200
| -20% | -$28.5K | ﹤0.01% | 4025 |
|
|
2019
Q4 | $132K | Buy |
90,400
+45,100
| +100% | +$75.5K | ﹤0.01% | 4201 |
|
|
2019
Q3 | $94K | Sell |
45,300
-33,900
| -43% | -$69.3K | ﹤0.01% | 3869 |
|
|
2019
Q2 | $193K | Sell |
79,200
-3,700
| -4% | -$8.07K | ﹤0.01% | 3741 |
|
|
2019
Q1 | $216K | Sell |
82,900
-25,300
| -23% | -$76.6K | ﹤0.01% | 3733 |
|
|
2018
Q4 | $342K | Sell |
108,200
-38,200
| -26% | -$130K | ﹤0.01% | 3050 |
|
|
2018
Q3 | $507K | Buy |
+146,400
| New | +$777K | ﹤0.01% | 3096 |
|
|
2018
Q1 | – | Sell |
-70,200
| Closed | -$344K | – | 5640 |
|
|
2017
Q4 | $344K | Sell |
70,200
-21,600
| -24% | -$125K | ﹤0.01% | 3426 |
|
|
2017
Q3 | $630K | Sell |
91,800
-9,100
| -9% | -$57.4K | ﹤0.01% | 2362 |
|
|
2017
Q2 | $670K | Sell |
100,900
-105,700
| -51% | -$741K | ﹤0.01% | 2143 |
|
|
2017
Q1 | $1.65M | Buy |
206,600
+101,900
| +97% | +$858K | 0.01% | 1327 |
|
|
2016
Q4 | $974K | Sell |
104,700
-10,500
| -9% | -$109K | ﹤0.01% | 1938 |
|
|
2016
Q3 | $1.22M | Buy |
+115,200
| New | +$1.15M | 0.01% | 1676 |
|
Other funds holding OPK
RCMNY
SC
WAM
DM
Wolverine Trading's OPK Position: Q1 2025 in Review
Wolverine Trading sold out of Opko Health (OPK) in Q1 2025, closing a stake of 97,722 shares — an estimated $144K sold.
Wolverine Trading first reported a position in OPK in Q3 2016 and held it in 27 quarters. The position peaked at $910K in Q1 2017. 255 funds tracked by Wall St. Rank hold OPK as of Q1 2025.
- Wolverine Trading reported no remaining Opko Health position as of Q1 2025 after selling out during the quarter.
- Wolverine Trading sold 97,722 Opko Health shares in Q1 2025, an estimated $144K.
- Wolverine Trading first reported a position in Opko Health in Q3 2016 and held it in 27 quarters.
- Wolverine Trading's Opko Health position peaked at $910K in Q1 2017.
- 255 funds tracked by Wall St. Rank held Opko Health as of Q1 2025.
Based on Wolverine Trading's 13F filing for Q1 2025, filed 15 May 2025.